LIZAFUSE Trademark

Trademark Overview

On Wednesday, April 25, 2018, a trademark application was filed for LIZAFUSE with the United States Patent and Trademark Office. The USPTO has given the LIZAFUSE trademark a serial number of 79235031. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, October 17, 2025. This trademark is owned by Midatech Ltd. The LIZAFUSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders
lizafuse

General Information

Serial Number79235031
Word MarkLIZAFUSE
Filing DateWednesday, April 25, 2018
Status709 - CANCELLED - SECTION 71
Status DateFriday, October 17, 2025
Registration Number5711883
Registration DateTuesday, April 2, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 15, 2019

Trademark Statements

Pseudo MarkLIZA FUSE
Goods and ServicesPharmaceutical preparations and substances for the treatment of oncological related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, October 17, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMidatech Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameMidatech Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameMidatech Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Thursday, June 28, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, July 2, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, July 3, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 7, 2018APPLICATION FILING RECEIPT MAILED
Wednesday, August 15, 2018ASSIGNED TO EXAMINER
Monday, August 20, 2018NON-FINAL ACTION WRITTEN
Tuesday, August 21, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 30, 2018REFUSAL PROCESSED BY MPU
Thursday, August 30, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, September 15, 2018REFUSAL PROCESSED BY IB
Monday, November 5, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 5, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 29, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 4, 2018ASSIGNED TO LIE
Thursday, December 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, December 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 26, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 9, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 9, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, January 15, 2019PUBLISHED FOR OPPOSITION
Tuesday, January 15, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, January 25, 2019NOTIFICATION PROCESSED BY IB
Tuesday, April 2, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, July 2, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, July 31, 2019FINAL DISPOSITION PROCESSED
Wednesday, July 31, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 16, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 4, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, November 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 2, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, October 17, 2025CANCELLED SECTION 71

Related Keywords

lizafuse related diseases disorders oncological treatment preparations substances pharmaceutical